To ensure the development of a cure for Parkinson's disease within this lifetime through an aggressively funded research agenda.
About the Organization:
Actor Michael J. Fox established the foundation in May 2000, shortly after announcing his retirement from the ABC television show Spin City. In 1998, he had publicly disclosed that he had been diagnosed with young-onset Parkinson's disease seven years earlier. His foundation has become the single largest funder of Parkinson's disease research outside of the U.S. government, with research and fundraising efforts extending across the country and around the world. To date, it has funded nearly $50 million in research, either directly or through partnerships.
The $1.5 million Target Validation Initiative validates potential drug targets for Parkinson's disease, which overcomes a big hurdle in the drug development process and could greatly facilitate the development of new therapeutic interventions and their translation to clinical trials. The Biomarker Initiative seeks to develop or validate a reliable diagnostic test, known as a biomarker, in order to accelerate understanding of how the disease progresses. The Cell Line II Initiative aims to advance the prospects for cell replacement therapies and lead to better cellular models. Under the Clinical Discovery Grants Program, researchers are invited to submit investigator-initiated grant applications to conduct new, novel, or innovative clinical research relevant to the cause, cure, prevention, or improved treatment of Parkinson's disease and its complications.
The MJFF Web site supplies a biography of Michael J. Fox; in-depth information about Parkinson's disease; a description of foundation-funded research, including grants awarded; articles and events; resources for patients, caregivers, and communities; frequently asked questions about the foundation; and a newsletter, which is available, along with updates, via e-mail. The most recent news and research are posted on the homepage.
The foundation is supported primarily through gifts from individuals, including memorial gifts, and from proceeds from benefits and other special events.